XML 118 R104.htm IDEA: XBRL DOCUMENT v3.25.1
Schedule II - Condensed Statement of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating Activities    
Net Income (Loss) $ 31,073 $ 21,686
Depreciation 3,320 2,760
Share-based compensation expense related to stock appreciation rights 394 425
Net gains on disposal of property (221) (204)
Net realized losses on other investments 87 118
Provision (benefit) for deferred income taxes 624 (4,234)
(Increase) decrease in current income taxes receivable 1,081 93
(Increase) decrease in other assets 2,635 621
Increase in current income taxes payable 276 0
Decrease in accounts payable and accrued liabilities 2,147 (10,408)
Net cash provided by (used in) operating activities 29,840 7,426
Investing Activities    
Purchases of short-term securities (115,924) (174,742)
Purchases of and net earnings from other investments (5,654) (3,006)
Proceeds from sales and maturities of short-term investments 170,407 166,362
Proceeds from sales and distributions of other investments 6,775 4,499
Purchases of property (7,423) (9,186)
Proceeds from disposals of property 275 529
Net cash provided by (used in) investing activities 1,747 (6,699)
Financing Activities    
Repurchases of common stock (1,099) (959)
Exercise of stock appreciation rights 0 0
Dividends paid (29,865) (11,048)
Net cash provided by (used in) financing activities (30,964) (12,007)
Net Increase (Decrease) in Cash and Cash Equivalents 623 (11,280)
Cash and Cash Equivalents, Beginning of Period 24,031  
Cash and Cash Equivalents, End of Period 24,654 24,031
Supplemental Disclosures:    
Non cash 1031 exchange proceeds receivable 0 (2,589)
Parent Company    
Operating Activities    
Net Income (Loss) 31,073 21,686
Equity in net earnings of subsidiaries (29,525) (19,670)
Depreciation 131 126
Accretion of investments, net (2,531) (2,924)
Share-based compensation expense related to stock appreciation rights 393 425
Net gains on disposal of property (184) (194)
Net investment (gains) losses on securities (79) 142
Net realized losses on other investments 309 21
Provision (benefit) for deferred income taxes 515 (433)
Decrease (increase) in receivables 3,325 (1,652)
(Increase) decrease in current income taxes receivable (1,917) 1,506
(Increase) decrease in other assets (407) 3,204
Decrease in accounts payable and accrued liabilities (696) (1,326)
Net cash provided by (used in) operating activities 407 911
Investing Activities    
Dividends received from subsidiaries 18,137 32,478
Purchases of fixed maturity and equity securities (50,146) (1,203)
Purchases of short-term securities (65,448) (127,789)
Purchases of and net earnings from other investments (5,001) (81)
Proceeds from sales and maturities of fixed maturity and equity securities 5,220 2,892
Proceeds from sales and maturities of short-term investments 124,472 107,083
Proceeds from sales and distributions of other investments 685 2
Purchases of property (72) (9)
Proceeds from disposals of property 0 206
Net cash provided by (used in) investing activities 27,847 13,579
Financing Activities    
Repurchases of common stock (1,099) (959)
Capital contribution to subsidiaries (447) (1,524)
Dividends paid (29,865) (11,048)
Net cash provided by (used in) financing activities (31,411) (13,531)
Net Increase (Decrease) in Cash and Cash Equivalents (3,157) 959
Cash and Cash Equivalents, Beginning of Period 4,409 3,450
Cash and Cash Equivalents, End of Period 1,252 4,409
Supplemental Disclosures:    
Income tax payments, net 6,273 8,320
Non cash 1031 exchange proceeds receivable $ 0 $ (2,589)